{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:40:07Z","timestamp":1792431607575,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"DOI":"10.1038\/s41431-026-02259-8","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T04:30:08Z","timestamp":1792384208000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deep intronic NIPBL variants underlie unresolved Cornelia de Lange syndrome revealed by integrated epigenomic and transcriptomic analysis"],"prefix":"10.1038","author":[{"given":"Sophie","family":"Rondeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1245-6606","authenticated-orcid":false,"given":"Jennifer","family":"Kerkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6363-0016","authenticated-orcid":false,"given":"Bekim","family":"Sadikovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2839-9856","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Cormier-Daire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"key":"2259_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41576-018-0031-0","volume":"19","author":"AD Kline","year":"2018","unstructured":"Kline AD, Moss JF, Selicorni A, Bisgaard AM, Deardorff MA, Gillett PM, et al. Diagnosis and management of Cornelia de Lange syndrome: first international consensus statement. Nat Rev Genet. 2018;19:649\u201366.","journal-title":"Nat Rev Genet"},{"key":"2259_CR2","first-page":"303","volume":"10","author":"J Liu","year":"2009","unstructured":"Liu J, Krantz ID. Cohesin and human disease. Annu Rev Genomics Hum Genet. 2009;10:303\u201320.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"2259_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1749-6632.2008.03450.x","volume":"1151","author":"D Dorsett","year":"2009","unstructured":"Dorsett D, Krantz ID. On the molecular etiology of Cornelia de Lange syndrome. Ann NY Acad Sci. 2009;1151:22\u201337.","journal-title":"Ann NY Acad Sci"},{"key":"2259_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fgene.2012.00171","volume":"3","author":"JA Horsfield","year":"2012","unstructured":"Horsfield JA, Print CG, M\u00f6nnich M. Diverse developmental disorders from the one ring: cohesinopathies. Front Genet. 2012;3:171.","journal-title":"Front Genet"},{"key":"2259_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-71177-6","volume":"17","author":"I Parenti","year":"2026","unstructured":"Parenti I, Hesters A, Gil-Salvador M, Duffy L, Kanber D, Beygo J, et al. Pathogenic variants in the cohesin loader subunit MAU2 underlie a distinct Cornelia de Lange Syndrome subtype. Nat Commun. 2026;17:3036.","journal-title":"Nat Commun"},{"key":"2259_CR6","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.cell.2014.11.021","volume":"159","author":"SSP Rao","year":"2014","unstructured":"Rao SSP, Huntley MH, Durand NC, Stamenova EK, Bochkov ID, Robinson JT, et al. A 3D map of the human ge. nome Cell. 2014;159:1665\u201380.","journal-title":"nome Cell"},{"key":"2259_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nature11049","volume":"485","author":"EP Nora","year":"2012","unstructured":"Nora EP, Lajoie BR, Schulz EG, Giorgetti L, Okamoto I, Servant N, et al. Spatial partitioning of the regulatory landscape. Nature. 2012;485:381\u20135.","journal-title":"Nature"},{"key":"2259_CR8","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1086\/424698","volume":"75","author":"LA Gillis","year":"2004","unstructured":"Gillis LA, McCallum J, Kaur M, DeScipio C, Yaeger D, Mariani A, et al. NIPBL mutational analysis in Cornelia de Lange syndrome. Am J Hum Genet. 2004;75:610\u201323.","journal-title":"Am J Hum Genet"},{"key":"2259_CR9","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1002\/humu.22430","volume":"34","author":"L Mannini","year":"2013","unstructured":"Mannini L, Cucco F, Quarantotti V, Krantz ID, Musio A. Mutation spectrum in Cornelia de Lange syndrome. Hum Mutat. 2013;34:1589\u201396.","journal-title":"Hum Mutat"},{"key":"2259_CR10","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/jmedgenet-2012-101477","volume":"50","author":"SA Huisman","year":"2013","unstructured":"Huisman SA, Redeker EJW, Maas SM, Mannens MMAM, Hennekam RCM. High rate of mosaicism in Cornelia de Lange syndrome. J Med Genet. 2013;50:339\u201344.","journal-title":"J Med Genet"},{"key":"2259_CR11","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/cge.12720","volume":"89","author":"M Nizon","year":"2016","unstructured":"Nizon M, Henry M, Michot C, Baumann C, Bazin A, Bessi\u00e8res B, et al. A series of 38 novel germline and somatic mutations of NIPBL in Cornelia de Lange syndrome. Clin Genet. 2016;89:584\u20139.","journal-title":"Clin Genet"},{"key":"2259_CR12","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00439-017-1809-4","volume":"136","author":"R Vaz-Drago","year":"2017","unstructured":"Vaz-Drago R, Cust\u00f3dio N, Carmo-Fonseca M. Deep intronic mutations and human disease. Hum Genet. 2017;136:1093\u2013111.","journal-title":"Hum Genet"},{"key":"2259_CR13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s13353-018-0444-7","volume":"59","author":"A Anna","year":"2018","unstructured":"Anna A, Monika G. Splicing mutations in human genetic disorders. J Appl Genet. 2018;59:253\u201368.","journal-title":"J Appl Genet"},{"key":"2259_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev.biochem.76.050106.093909","volume":"76","author":"YF Chang","year":"2007","unstructured":"Chang YF, Imam JS, Wilkinson MF. Nonsense-mediated decay. Annu Rev Biochem. 2007;76:51\u201374.","journal-title":"Annu Rev Biochem"},{"key":"2259_CR15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1242\/jcs.181008","volume":"129","author":"T Kurosaki","year":"2016","unstructured":"Kurosaki T, Maquat LE. NMD in humans. J Cell Sci. 2016;129:461\u20137.","journal-title":"J Cell Sci"},{"key":"2259_CR16","first-page":"1882","volume":"43","author":"J Coursimault","year":"2022","unstructured":"Coursimault J, Cassinari K, Lecoquierre F, Quenez O, Coutant S, Derambure C, et al. Deep intronic NIPBL variant causing aberrant splicing. Hum Genome Var. 2022;43:1882\u201397.","journal-title":"Hum Genome Var"},{"key":"2259_CR17","doi-asserted-by":"publisher","first-page":"110468","DOI":"10.1016\/j.ygeno.2022.110468","volume":"114","author":"R Seyama","year":"2022","unstructured":"Seyama R, Uchiyama Y, Ceroni JRM, Kim VEH, Furquim I, Honjo RS, et al. Pathogenic variants detected by RNA sequencing in Cornelia de Lange syndrome. Genomics. 2022;114:110468.","journal-title":"Genomics"},{"key":"2259_CR18","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s41436-020-01096-4","volume":"23","author":"B Sadikovic","year":"2021","unstructured":"Sadikovic B, Levy MA, Kerkhof J, Aref-Eshghi E, Schenkel L, Stuart A, et al. Clinical epigenomics: genome-wide DNA methylation analysis for the diagnosis of Mendelian disorders. Genet Med. 2021;23:1065\u201374.","journal-title":"Genet Med"},{"key":"2259_CR19","doi-asserted-by":"crossref","unstructured":"Aref-Eshghi E, Kerkhof J, Pedro VP, Barat-Houari M, Ruiz-Pallares N, et al. Groupe DI, France evaluation of DNA methylation episignatures for diagnosis and phenotype correlations in 42 Mendelian neurodevelopmental disorders. Am J Hum Genet. 2020;106:356\u201370.","DOI":"10.1016\/j.ajhg.2020.01.019"},{"key":"2259_CR20","first-page":"100075","volume":"3","author":"A Michael","year":"2021","unstructured":"Michael A, Levy H, McConkey J, Kerkhof M, Barat-H, Sara B, Elisa B, et al. Novel diagnostic DNA methylation episignatures expand and refine the epigenetic landscapes of Mendelian disorders. Hum Genet Genomics Adv. 2021;3:100075.","journal-title":"Hum Genet Genomics Adv"},{"key":"2259_CR21","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ajhg.2019.03.008","volume":"104","author":"E Aref-Eshghi","year":"2019","unstructured":"Aref-Eshghi E, Bend EG, Colaiacovo S, Caudle M, Chakrabarti R, Napier M, et al. Diagnostic utility of genome-wide DNA methylation testing in genetically unsolved individuals with suspected hereditary conditions. Am J Hum Genet. 2019;104:685\u2013700.","journal-title":"Am J Hum Genet"},{"key":"2259_CR22","doi-asserted-by":"publisher","first-page":"101075","DOI":"10.1016\/j.gim.2024.101075","volume":"26","author":"J Kerkhof","year":"2024","unstructured":"Kerkhof J, Rastin C, Levy MA, Relator R, McConkey H, et al. Diagnostic utility and reporting recommendations for clinical DNA methylation episignature testing in genetically undiagnosed rare diseases. Genet Med. 2024;26:101075.","journal-title":"Genet Med"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02259-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02259-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02259-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:02:46Z","timestamp":1792429366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02259-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,19]]},"references-count":22,"alternative-id":["2259"],"URL":"https:\/\/doi.org\/10.1038\/s41431-026-02259-8","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,19]]},"assertion":[{"value":"31 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"BS is a shareholder in EpiSign Inc.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This research was conducted as part of the research programmes: Imagine\/INSERM U1163 (DC-2019\u20133504). In accordance with data protection regulations, informed consent for the use of DNA in analyses complementary to sequencing was obtained from each patient by. their attending physician. All samples were anonymised at the clinical site prior to their transfer to the laboratory, where they were used for downstream analyses. This study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Written informed consent for the use of biological samples and for the publication of clinical details was obtained by the treating physician. Consent to publish pictures of patient 7 and 9 were also obtained.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}}]}}